EcoDrugPlus

Prostaglandin E Receptor 4

Ensembl ID : ENSDNOG00000044393
Gene Symbol: PTGER4
4 Cross references
275 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSDNOG00000031456
Gene Symbol: PTGFR
4 Cross references
195 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSDNOG00000012552
Gene Symbol: PTGS1
2 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSDNOG00000002864
Gene Symbol: PTGS2
4 Cross references
240 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSDNOG00000011910
Gene Symbol: PSMA2
4 Cross references
236 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSDNOG00000004077
Gene Symbol: PSMA3
3 Cross references
238 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSDNOG00000017230
Gene Symbol: PSMA4
2 Cross references
253 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSDNOG00000012358
Gene Symbol: PSMA5
2 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSDNOG00000036190
Gene Symbol: PSMA6
2 Cross references
289 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSDNOG00000002450
Gene Symbol: PSMA8
4 Cross references
198 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSDNOG00000019502
Gene Symbol: PSMB1
2 Cross references
217 Possible Orthologues:

Proteasome 20s Subunit Beta 2

Ensembl ID : ENSDNOG00000017663
Gene Symbol: PSMB2
2 Cross references
221 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).